decitabine
- Product NDC
- 25021-231
- 11-digit product format
- 250210231
- Labeler code
- 25021
- Product ID
- 25021-231_eb76d3dd-62e1-4922-a419-4951458363fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- decitabine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA207100
- Marketing category
- ANDA
- Marketing start
- 2018-08-15
- Marketing end
- 2023-03-31
- Substance
- DECITABINE
- Active strength
- 50 mg/20mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-231-20 | 25021023120 | 1 VIAL in 1 CARTON (25021-231-20) > 20 mL in 1 VIAL | 1 vial | 2018-08-15 | 0000-00-00 | No | No | Current |